AMUB on NYSE
UBS AG
UBS AG is a national commercial bank, listed on NYSE (AMUB).1
Price unavailable
Last updated Oct 21, 2026.
Overview
$3.6BNet income, fiscal 20252
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
4.0%Return on equity2
Financial statements
No quarterly figures reported.
Every line of the income statement as filed: the last 3 fiscal years, latest first.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | $26.5B | $29.0B | $22.4B |
| Interest expense from financial instruments measured at amortized cost | -$26.5B | -$29.7B | -$19.6B |
| Net interest income from financial instruments measured at fair value through profit or loss and other | $6.3B | $5.5B | $1.8B |
| Net interest income | $6.4B | $4.7B | $4.6B |
| Other net income from financial instruments measured at fair value through profit or loss | $14.0B | $13.0B | $9.9B |
| Fee and commission income | $30.1B | $25.8B | $20.4B |
| Fee and commission expense | -$2.7B | -$2.4B | -$1.8B |
| Net fee and commission income | $27.4B | $23.4B | $18.6B |
| Other income | -$17.0M | $1.2B | $566.0M |
| Total revenues | $47.7B | $42.3B | $33.7B |
| Credit loss expense / (release) | $549.0M | $544.0M | $143.0M |
| Personnel expenses | $22.7B | $20.0B | $15.7B |
| General and administrative expenses | $17.5B | $16.5B | $11.1B |
| Depreciation, amortization and impairment of non-financial assets | $2.9B | $2.8B | $2.2B |
| Operating expenses | $43.0B | $39.3B | $29.0B |
| Operating profit / (loss) before tax | $4.1B | $2.4B | $4.5B |
| Tax expense / (benefit) | $534.0M | $900.0M | $1.2B |
| Net profit / (loss) | $3.6B | $1.5B | $3.3B |
| Net profit / (loss) attributable to non-controlling interests | $26.0M | $51.0M | $25.0M |
| Net profit / (loss) attributable to shareholders | $3.5B | $1.5B | $3.3B |
No quarter-by-quarter statement was filed.
No quarterly figures reported.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and balances at central banks | $209.9B | $223.3B | ||
| Amounts due from banks | $19.2B | $18.1B | ||
| Receivables from securities financing transactions measured at amortized cost | $83.7B | $118.3B | ||
| Cash collateral receivables on derivative instruments | $41.6B | $44.0B | ||
| Loans and advances to customers | $658.8B | $587.3B | ||
| Other financial assets measured at amortized cost | $72.0B | $59.3B | ||
| Total financial assets measured at amortized cost | $1.1T | $1.1T | ||
| Financial assets at fair value held for trading | $174.9B | $159.2B | ||
| of which: assets pledged as collateral that may be sold or repledged by counterparties | $44.6B | $38.5B | ||
| Derivative financial instruments | $148.3B | $186.4B | ||
| Brokerage receivables | $35.6B | $25.9B | ||
| Financial assets at fair value not held for trading | $107.3B | $95.2B | ||
| Total financial assets measured at fair value through profit or loss | $466.1B | $466.7B | ||
| Financial assets measured at fair value through other comprehensive income | $13.9B | $2.2B | ||
| Investments in associates | $2.3B | $2.3B | $983.0M | |
| Property, equipment and software | $12.1B | $12.1B | $11.0B | |
| Goodwill and intangible assets | $6.7B | $6.7B | ||
| Deferred tax assets | $11.1B | $10.5B | ||
| Other non-financial assets | $19.9B | $17.3B | ||
| Total assets | $1.6T | $1.6T | $1.2T | |
| Amounts due to banks | $24.4B | $23.3B | ||
| Payables from securities financing transactions measured at amortized cost | $16.2B | $14.8B | ||
| Cash collateral payables on derivative instruments | $34.7B | $36.4B | ||
| Customer deposits | $796.3B | $749.5B | ||
| Funding from UBS Group AG measured at amortized cost | $110.6B | $107.9B | ||
| Debt issued measured at amortized cost | $100.2B | $101.1B | ||
| Other financial liabilities measured at amortized cost | $16.6B | $21.8B | ||
| Total financial liabilities measured at amortized cost | $1.1T | $1.1T | ||
| Financial liabilities at fair value held for trading | $53.7B | $35.2B | ||
| Derivative financial instruments | $156.3B | $180.7B | ||
| Brokerage payables designated at fair value | $62.2B | $49.0B | ||
| Debt issued designated at fair value | $107.5B | $102.6B | ||
| Other financial liabilities designated at fair value | $35.3B | $34.0B | ||
| Total financial liabilities measured at fair value through profit or loss | $415.0B | $401.6B | ||
| Provisions | $3.6B | $5.1B | ||
| Other non-financial liabilities | $10.3B | $11.9B | ||
| Total liabilities | $1.5T | $1.5T | ||
| Share capital | $386.0M | $386.0M | ||
| Share premium | $84.8B | $84.8B | ||
| Retained earnings | -$2.1B | $7.8B | ||
| Other comprehensive income recognized directly in equity, net of tax | $5.8B | $1.0B | ||
| Equity attributable to shareholders | $88.8B | $94.0B | ||
| Equity attributable to non-controlling interests | $334.0M | $662.0M | ||
| Total equity | $89.2B | $94.7B | $55.6B | $56.9B |
| Total liabilities and equity | $1.6T | $1.6T |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and balances at central banks | $209.9B | $223.3B | ||
| Amounts due from banks | $19.2B | $18.1B | ||
| Receivables from securities financing transactions measured at amortized cost | $83.7B | $118.3B | ||
| Cash collateral receivables on derivative instruments | $41.6B | $44.0B | ||
| Loans and advances to customers | $658.8B | $587.3B | ||
| Other financial assets measured at amortized cost | $72.0B | $59.3B | ||
| Total financial assets measured at amortized cost | $1.1T | $1.1T | ||
| Financial assets at fair value held for trading | $174.9B | $159.2B | ||
| of which: assets pledged as collateral that may be sold or repledged by counterparties | $44.6B | $38.5B | ||
| Derivative financial instruments | $148.3B | $186.4B | ||
| Brokerage receivables | $35.6B | $25.9B | ||
| Financial assets at fair value not held for trading | $107.3B | $95.2B | ||
| Total financial assets measured at fair value through profit or loss | $466.1B | $466.7B | ||
| Financial assets measured at fair value through other comprehensive income | $13.9B | $2.2B | ||
| Investments in associates | $2.3B | $2.3B | $983.0M | |
| Property, equipment and software | $12.1B | $12.1B | $11.0B | |
| Goodwill and intangible assets | $6.7B | $6.7B | ||
| Deferred tax assets | $11.1B | $10.5B | ||
| Other non-financial assets | $19.9B | $17.3B | ||
| Total assets | $1.6T | $1.6T | $1.2T | |
| Amounts due to banks | $24.4B | $23.3B | ||
| Payables from securities financing transactions measured at amortized cost | $16.2B | $14.8B | ||
| Cash collateral payables on derivative instruments | $34.7B | $36.4B | ||
| Customer deposits | $796.3B | $749.5B | ||
| Funding from UBS Group AG measured at amortized cost | $110.6B | $107.9B | ||
| Debt issued measured at amortized cost | $100.2B | $101.1B | ||
| Other financial liabilities measured at amortized cost | $16.6B | $21.8B | ||
| Total financial liabilities measured at amortized cost | $1.1T | $1.1T | ||
| Financial liabilities at fair value held for trading | $53.7B | $35.2B | ||
| Derivative financial instruments | $156.3B | $180.7B | ||
| Brokerage payables designated at fair value | $62.2B | $49.0B | ||
| Debt issued designated at fair value | $107.5B | $102.6B | ||
| Other financial liabilities designated at fair value | $35.3B | $34.0B | ||
| Total financial liabilities measured at fair value through profit or loss | $415.0B | $401.6B | ||
| Provisions | $3.6B | $5.1B | ||
| Other non-financial liabilities | $10.3B | $11.9B | ||
| Total liabilities | $1.5T | $1.5T | ||
| Share capital | $386.0M | $386.0M | ||
| Share premium | $84.8B | $84.8B | ||
| Retained earnings | -$2.1B | $7.8B | ||
| Other comprehensive income recognized directly in equity, net of tax | $5.8B | $1.0B | ||
| Equity attributable to shareholders | $88.8B | $94.0B | ||
| Equity attributable to non-controlling interests | $334.0M | $662.0M | ||
| Total equity | $89.2B | $94.7B | $55.6B | $56.9B |
| Total liabilities and equity | $1.6T | $1.6T |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net profit / (loss) | $3.6B | $1.5B | $3.3B |
| Depreciation, amortization and impairment of non-financial assets | $2.9B | $2.8B | $2.2B |
| Credit loss expense / (release) | $549.0M | $544.0M | $143.0M |
| Share of net (profit) / loss of associates and joint ventures and impairment related to associates | -$77.0M | -$73.0M | $163.0M |
| Deferred tax expense / (benefit) | -$703.0M | -$1.1B | -$222.0M |
| Net loss / (gain) from investing activities | -$346.0M | $207.0M | -$225.0M |
| Net loss / (gain) from financing activities | $17.7B | -$3.6B | $4.9B |
| Other net adjustments | -$27.9B | $14.3B | -$10.4B |
| Amounts due from banks and amounts due to banks | -$154.0M | -$708.0M | -$10.1B |
| Receivables from securities financing transactions measured at amortized cost | $40.5B | -$19.6B | -$5.0B |
| Payables from securities financing transactions measured at amortized cost | $810.0M | $471.0M | $1.5B |
| Cash collateral on derivative instruments | $1.2B | -$6.1B | $1.2B |
| Loans and advances to customers | -$12.5B | $21.2B | $3.7B |
| Customer deposits | -$9.3B | -$13.4B | $6.5B |
| Financial assets and liabilities at fair value held for trading and derivative financial instruments | $24.9B | -$27.6B | -$16.0B |
| Brokerage receivables and payables | $2.9B | $1.8B | -$6.1B |
| Financial assets at fair value not held for trading and other financial assets and liabilities | -$13.0B | $2.3B | -$4.7B |
| Provisions and other non-financial assets and liabilities | -$4.6B | $1.5B | $2.3B |
| Income taxes paid, net of refunds | -$1.8B | -$1.5B | -$1.5B |
| Net cash flow from / (used in) operating activities | $24.6B | -$27.1B | -$28.2B |
| Purchase of subsidiaries, business, associates and intangible assets | -$17.0M | -$64.0M | -$4.0M |
| Disposal of subsidiaries, business, associates and intangible assets | $653.0M | $233.0M | $109.0M |
| Purchase of property, equipment and software | -$1.9B | -$1.5B | -$1.3B |
| Disposal of property, equipment and software | $209.0M | $71.0M | $33.0M |
| Purchase of financial assets measured at fair value | -$16.7B | -$4.6B | -$4.2B |
| Disposal and redemption of financial assets measured at fair value | $5.2B | $4.6B | $4.2B |
| Purchase of debt securities measured at amortized cost | -$21.6B | -$6.0B | -$14.2B |
| Disposal and redemption of debt securities measured at amortized cost | $11.8B | $8.4B | $10.4B |
| Net cash flow from / (used in) investing activities | -$22.3B | $122.4B | -$4.9B |
| Repayment of Swiss National Bank funding | -$10.3B | ||
| Net issuance (repayment) of short-term debt measured at amortized cost | $1.7B | -$6.2B | $7.2B |
| Distributions paid on UBS AG shares | -$13.0B | -$3.0B | -$6.0B |
| Issuance of debt designated at fair value and long-term debt measured at amortized cost | $131.9B | $103.0B | $104.6B |
| Repayment of debt designated at fair value and long-term debt measured at amortized cost | -$153.0B | -$118.3B | -$85.5B |
| Inflows from securities financing transactions measured at amortized cost | $2.3B | $6.3B | |
| Outflows from securities financing transactions measured at amortized cost | -$2.7B | -$2.7B | |
| Net cash flows from other financing activities | -$935.0M | -$965.0M | -$501.0M |
| Net cash flow from / (used in) financing activities | -$33.8B | -$32.1B | $19.7B |
| Net cash flow from / (used in) operating, investing and financing activities | -$31.5B | $63.2B | -$13.4B |
| Effects of exchange rate differences on cash and cash equivalents | $19.1B | -$10.3B | $8.7B |
| Interest received in cash | $42.7B | $48.3B | $32.6B |
| Interest paid in cash | $37.9B | $41.5B | $26.7B |
| Dividends on equity investments, investment funds and associates received in cash | $3.2B | $2.8B | $2.2B |
No quarter-by-quarter statement was filed.
Corporate structure
UBS AG sits at the top of its group. 4 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
- UBS AG V8
- Eaton Vance Ltd Duration Income Fund Stake · Boston, Massachusetts, United States
- Eaton Vance Senior Floating-Rate Trust Stake · Boston, Massachusetts
- Eaton Vance Senior Income Trust Stake · Boston, Massachusetts, United States
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (3 companies). Each entity in the chart links to its source.
What it owns
What UBS AG reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $231.0B2 Dec 31, 2025 | $243.4B2 Dec 31, 2024 | −5.1% |
Intangibles and goodwill
Filings
52,972 filings to the SEC since October 2021: 3 annual reports, 52,969 other. The latest 20:
- Oct 15, 2026424B3 EDGAR
- Oct 15, 2026FWP EDGAR
- Oct 15, 2026424B3 EDGAR
- Oct 15, 2026424B2 EDGAR
- Oct 15, 2026424B2 EDGAR
- Oct 15, 2026FWP EDGAR
- Oct 15, 2026424B2 EDGAR
- Oct 15, 2026424B2 EDGAR
- Oct 15, 2026424B2 EDGAR
- Oct 15, 2026424B2 EDGAR
- Oct 15, 2026424B2 EDGAR
- Oct 15, 2026424B2 EDGAR
- Oct 15, 2026424B2 EDGAR
- Oct 15, 2026424B2 EDGAR
- Oct 15, 2026424B2 EDGAR
- Oct 15, 2026424B2 EDGAR
- Oct 15, 2026424B2 EDGAR
- Oct 15, 2026424B2 EDGAR
- Oct 15, 2026424B2 EDGAR
- Oct 15, 2026424B2 EDGAR
The 52,972 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Stakes it holds
UBS AG has told the SEC it owns more than 5% of 3 companies, latest first (Schedules 13D and 13G).
- Eaton Vance Ltd Duration Income FundSCHEDULE 13G/A May 29, 20266
- Eaton Vance Senior Floating-Rate TrustSCHEDULE 13G/A May 29, 20267
- Eaton Vance Senior Income TrustSCHEDULE 13G/A May 29, 20268
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| North Capital, Inc. | 87,219 | $1.9M | 1.4% | −911 |
| Susquehanna International Group, Llp | 51,161 | $1.1M | 0.0% | New |
| Hamilton Wealth, LLC | 11,713 | $253.5K | 0.0% | No change |
| Morgan Stanley | 1,502 | $32.5K | 0.0% | −6 |
| Wells Fargo & Company/mn | 1,011 | $21.9K | 0.0% | −6,150 |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How UBS AG is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARUBS AG1
- CIK0001114446
- Filer statusNon-accelerated filer not a shell company9
- Incorporated inSwitzerland9
- Fiscal year endsDecember 311
- Industry code (SIC)6021 National Commercial Banks1
- SEC reviewing officeOffice of Finance, Division of Corporation Finance1
- Business addressBahnhofstrasse 45, Zurich, V8 CH 80011
- Mailing address600 Washington Blvd., Stamford, CT 069011
- Phone203-719-52411
- Shares outstanding3,858,408,466 shares as of Dec 31, 20259
- AuditorErnst & Young Ltd, Basel, Switzerland PCAOB ID 1460; no auditor attestation of internal control over financial reporting9
- On EDGAR sinceJul 28, 20001
- Filings123,526 in all: 424B2 (105,599), FWP (11,601), 6-K (2,223), 424B3 (1,828), SC 13G/A (598), SC 13G (271), 4 (208), 3 (143)1
All 76 form types
8-A12B (128), 425 (101), 25-NSE (81), 424B8 (65), SC 13D/A (56), 13F-HR (39), CORRESP (38), SC 13D (35), UPLOAD (32), 11-K (30), 20-F (26), CERTNYS (25), 25 (23), 8-A12B/A (23), CERTARCA (21), 13F-NT (20), 13F-HR/A (18), CERTAMX (18), S-8 (18), F-N (16), SC TO-T/A (15), CERTPAC (14), SC 14D9/A (14), 424B5 (13), 5 (13), IRANNOTICE (13), SBSE-A/A (13), POS AM (12), CERT (11), 6-K/A (10), EFFECT (9), F-3/A (8), F-3ASR (8), NO ACT (8), F-3 (7), 4/A (6), 40-APP (6), APP ORDR (5), 20-F/A (4), REGDEX (4), 13FCONP (3), 40-6B/A (3), 40-APP/A (3), APP NTC (3), F-1 (3), F-4 (3), NT 11-K (3), SCHEDULE 13G/A (3), 424B1 (2), 8-A12G (2), F-1/A (2), POS EX (2), POSASR (2), 11-K/A (1), 15-12B (1), 305B2 (1), 6B NTC (1), 6B ORDR (1), DEL AM (1), DRS (1), F-3MEF (1), F-4/A (1), RW (1), S-8 POS (1), SBSE-A (1), SBSE-C (1), SC 14D9 (1), SC TO-T (1)
- Latest filingsAnnual report (20-F) Mar 9, 2026
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARUBS AG filings on SEC EDGAR
- 2SEC EDGARUBS AG 10-K for fiscal 2025
- 3SEC EDGARUBS AG filings on SEC EDGAR
- 4SEC EDGARUBS AG 10-K for fiscal 2021
- 5SEC EDGARUBS AG 10-K for fiscal 2022
- 6
- 7
- 8
- 9